Press Releases

NEW YORK, Feb. 25, 2020 /PRNewswire/ -- The Kinetix Group (TKG) has announced the celebration of its 20-year anniversary as a recognized leader and innovator in healthcare market strategy consulting, innovation, and commercialization. TKG's unique business model blends agency services with strategic consulting that attracts both pharma plus health system and payer clien

VANCOUVER, British Columbia, Feb. 25, 2020 /PRNewswire/ -- Else Nutrition, a game-changing developer and marketer of clean-ingredient, pl

EXTON, Pa., Feb. 25, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, a

STAINES-UPON-THAMES, United Kingdom, Feb. 25, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK) ("Mallinckrodt" or the "Company") today announced that the Company and its specialty generics-focused subsidiaries Mallinckrodt LLC, SpecGx LLC and certain other affiliates (collectively, "Specialty Generics") have reached an agreement in prin

NORTH CHICAGO, Ill., Feb. 25, 2020 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of February 21, 2020 its issued share capital, excluding treasury shares, is comprised of 1,481,908,359 shares of common stock with a par value of $0.

VANCOUVER, Feb. 25, 2020 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF), one of the Canada's leading recreational cannabis retailers, is pleased to announce the opening of their next licensed cannabis retail store in Calgary, AB. The store, opening in the bedroom community of Shawcliffe,

JERUSALEM, Feb. 25, 2020 /PRNewswire/ -- KAHR Medical Ltd., a biopharmaceutical company developing a novel drug platform based on bi-functional, immunotherapeutic fusion proteins known as Dual Signaling Proteins ("DSP") today announced that it has raised

STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) invites investors, analysts and the media to a R&D Day in Stockholm, Monday March 2, 2020, at 14:00 to 16:30 CET.The presentations will, among other things, address new clinical r

HELSINKI, Feb. 25, 2020 /PRNewswire/ -- Topline analysis confirms positive safety and tolerability of CDNF in advanced-stage Parkinson's disease patients, with encouraging biological responses as measured by PET imaging in some patients. Results from the second part of trial, in which all patients will receive CDNF for an additional six months, are expected in Q3 202

LUND, Sweden, Feb. 25, 2020 /PRNewswire/ --  Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company's management team will participate in the following upcoming investor conferences: Cowen and Company's 40th Annual Health Care Conference in